Table 2.

Other peritransplant characteristics.

	Older adults (65+) n=91	Younger adults (40–60 years of age) n=91	p value
Time from dialysis to transplant in days, median (range)	1308 [38, 4971]	1372 [14, 7037]	0.83
Time on the waiting list in days, median [range]	589 [0,2336]	467 [0,4598]	0.83
Ischemia & surgical times in minutes, median [range]
Cold	996 [10,2505]	858 [32,2197]	0.30
Warm	28 [5,63]	34 [18,60]	0.06
Surgery	234 [132, 628]	236 [148, 439]	0.95
PRA (%), median [range]	0 [0,99]	0 [0,100]	NS
Induction regimen, n(%)
Basiliximab	44 (48.4)	45 (49.5)	0.88
ATG	27 (29.7)	31 (34.1)	0.53
None†	18 (19.8)	15 (16.5)	0.56
Ureteral stent used, n(%)	71 (78.0)	69 (75.8)	0.86
Maintenance immunosuppression, n(%)
Prednisone	89 (97.8)	88 (96.7)	0.61
MMF	88 (96.7)	88 (96.7)	1
Tacrolimus	90 (98.9)	88 (96.7)	0.62
Sirolimus	0 (0.0)	1 (1.1)	NS
Everolimus	2 (2.2)	0 (0.0)	NS
Belatacept	0 (0.0)	1 (1.1)	NS
Total length of mechanical ventilation in days, median (IQR)‡	0(0,0)	0(0,0)	NS
Any versus none n (%)	10 (11.0)	7(7.69)	0.62
Transfusions (PRBCs) during transplant surgery, n(%)	7 (7.69)	9 (9.89)	0.79
Length of hospital stay (days), median (IQR)	6 (5,9)	5 (4,8)	0.04
Delayed graft function, n(%)	24 (26.4)	15 (16.7)	0.15
Days on dialysis after transplant, median (IQR)	9 (5, 16)	7 (1, 11)	0.26
Discharge location
Home	87(95.6)	91(100.00)	NS
Nursing Home	1(1.10)	0.0(0.00)
Hospice	1(1.10)	0.0(0.00)
Death during transplant admission	2(2.20)	0.0(0.00)

PRA: panel reactive antibodies. ATG: Anti-thymocyte globulin. MMF: mycophenolate mofetil. PRBCs: packed red blood cells NS: not significant.

^†No induction immunosuppression would still involve methylprednisolone as per protocol.

^‡Total days of mechanical ventilation during transplant admission.